{
    "medical_history": {
        "chief_complaint": "Erythrocytosis during testosterone treatment and SGLT2 inhibitor therapy in a patient with hypogonadism and type 2 diabetes mellitus",
        "history_of_present_illness": "Patient started testosterone replacement therapy 7 months prior to presentation. Three months after initiating SGLT2i, the patient experienced a significant increase in hematocrit, hemoglobin, and red blood cell count, although he lost 7.5 kg and achieved good glycemic control.",
        "past_medical_history": "10-year history of type 2 diabetes mellitus treated with metformin, glimepiride, and exenatide. Also has a history of class I obesity, uncomplicated arterial hypertension, and hypercholesterolemia treated with amlodipine, telmisartan, hydrochlorothiazide, and simvastatin. Underwent unilateral orchiectomy for cryptorchidism at age 16.",
        "family_history": "Not specified.",
        "social_history": "Retired, nonsmoking man."
    }
}